Literature DB >> 24120603

Extramedullary haematopoiesis correlates with genotype and absence of cardiac iron overload in polytransfused adults with thalassaemia.

Paolo Ricchi1, Massimiliano Ammirabile1, Anna Spasiano1, Silvia Costantini1, Tiziana Di Matola2, Alessia Pepe3, Patrizia Cinque1, Leonilde Pagano1, Maddalena Casale1, Aldo Filosa1, Luciano Prossomariti1.   

Abstract

BACKGROUND: The mechanisms responsible for the sporadic occurrence of extramedullary haematopoiesis in polytransfused thalassaemic patients have not yet been clarified. In this study we tried to elucidate the influence of genotype and other factors on the presence of extramedullary haematopoiesis.
MATERIALS AND METHODS: We performed a retrospective database review of our polytransfused thalassaemic patients between January 2006 and December 2011. Demographic, transfusional, genetic, radiological and biochemical data were collected and statistically analysed.
RESULTS: Extramedullary haematopoiesis was found in 18 out of 67 patients (27%). All of them were splenectomised, had a higher nucleated red blood cell count and higher levels of the soluble form of transferrin receptor with respect to patients without extramedullary haematopoiesis; furthermore, patients with EMH had a lower transfusional iron intake and a higher pre-transfusion haemoglobin level as compared with those without extramedullary haematopoiesis. Ten out of the 18 patients with extramedullary haematopoiesis were compound heterozygotes for IVS 1-6/codon 39. A high frequency of thrombotic events was also recorded among all patients followed at our centre with this genetic profile. DISCUSSION: Among our cohort of thalassaemic polytransfused patients, extramedullary haematopoiesis was not such a rare event. Furthermore, we identified a group of patients, most of whom were compound heterozygotes for IVS 1-6/codon 39, with increased soluble transferrin receptor levels and excessive expansion of erythroid marrow probably responsible for the tendency to develop extramedullary haematopoiesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24120603      PMCID: PMC3934250          DOI: 10.2450/2013.0287-12

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  19 in total

1.  Effect of transfusional iron intake on response to chelation therapy in beta-thalassemia major.

Authors:  Alan R Cohen; Ekkehard Glimm; John B Porter
Journal:  Blood       Date:  2007-10-19       Impact factor: 22.113

2.  Multicenter validation of the magnetic resonance T2* technique for segmental and global quantification of myocardial iron.

Authors:  Anna Ramazzotti; Alessia Pepe; Vincenzo Positano; Giuseppe Rossi; Daniele De Marchi; Maria Gabriella Brizi; Antongiulio Luciani; Massimo Midiri; Giuseppina Sallustio; Gianluca Valeri; Vincenzo Caruso; Michele Centra; Paolo Cianciulli; Vincenzo De Sanctis; Aurelio Maggio; Massimo Lombardi
Journal:  J Magn Reson Imaging       Date:  2009-07       Impact factor: 4.813

Review 3.  Paraspinal extramedullary hematopoiesis in patients with thalassemia intermedia.

Authors:  Rachid Haidar; Hani Mhaidli; Ali T Taher
Journal:  Eur Spine J       Date:  2010-03-05       Impact factor: 3.134

Review 4.  Thalassemia intermedia: revisited.

Authors:  Ali Taher; Hussain Isma'eel; Maria D Cappellini
Journal:  Blood Cells Mol Dis       Date:  2006-06-05       Impact factor: 3.039

5.  Relationship between transfusion regimen and suppression of erythropoiesis in beta-thalassaemia major.

Authors:  M Cazzola; P De Stefano; L Ponchio; F Locatelli; Y Beguin; C Dessi; S Barella; A Cao; R Galanello
Journal:  Br J Haematol       Date:  1995-03       Impact factor: 6.998

Review 6.  Pathophysiology of transfusional iron overload: contrasting patterns in thalassemia major and sickle cell disease.

Authors:  John B Porter
Journal:  Hemoglobin       Date:  2009       Impact factor: 0.849

7.  Absence of cardiac siderosis despite hepatic iron overload in Italian patients with thalassemia intermedia: an MRI T2* study.

Authors:  Alberto Roghi; Maria Domenica Cappellini; John C Wood; Khaled M Musallam; Pedrotti Patrizia; Maria Rosaria Fasulo; Claudia Cesaretti; Ali T Taher
Journal:  Ann Hematol       Date:  2009-12-17       Impact factor: 3.673

8.  Hypocholesterolemia in adult patients with thalassemia: a link with the severity of genotype in thalassemia intermedia patients.

Authors:  Paolo Ricchi; Massimiliano Ammirabile; Anna Spasiano; Silvia Costantini; Tiziana Di Matola; Patrizia Cinque; Leonilde Pagano; Luciano Prossomariti
Journal:  Eur J Haematol       Date:  2009-03       Impact factor: 2.997

9.  Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.

Authors:  Adlette Inati; Khaled M Musallam; John C Wood; Marwan Sheikh-Taha; Linda Daou; Ali T Taher
Journal:  Eur J Haematol       Date:  2009-09-08       Impact factor: 2.997

10.  No evidence for myocardial iron overload and free iron species in multitransfused patients with sickle/beta-thalassaemia.

Authors:  Hussam Ghoti; Orly Goitein; Ariel Koren; Carina Levin; Tamar Kushnir; Eliezer Rachmilewitz; Eli Konen
Journal:  Eur J Haematol       Date:  2009-09-29       Impact factor: 2.997

View more
  7 in total

1.  Soluble form of transferrin receptor as a biomarker of overall morbidity in patients with non-transfusion-dependent thalassaemia: a cross-sectional study.

Authors:  Paolo Ricchi; Massimiliano Ammirabile; Silvia Costantini; Anna Spasiano; Tiziana Di Matola; Roberto Verna; Alessia Pepe; Patrizia Cinque; Caterina Saporito; Aldo Filosa; Leonilde Pagano
Journal:  Blood Transfus       Date:  2016-05-03       Impact factor: 3.443

2.  Phosphatidylserine-exposed red blood cells and ineffective erythropoiesis biomarkers in patients with thalassemia.

Authors:  Siriyakorn Chansai; Supawadee Yamsri; Supan Fucharoen; Goonnapa Fucharoen; Nattiya Teawtrakul
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

3.  The Correlation Between Ineffective Erythropoiesis Biomarkers and Development of Extramedullary Hematopoiesis in Patients with Thalassemia.

Authors:  Siriyakorn Chansai; Supawadee Yamsri; Supan Fucharoen; Goonnapa Fucharoen; Nattiya Teawtrakul
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-07-01       Impact factor: 3.122

4.  Genotypic groups as risk factors for cardiac magnetic resonance abnormalities and complications in thalassemia major: a large, multicentre study.

Authors:  Laura Pistoia; Antonella Meloni; Paolo Ricchi; Aldo Filosa; Roberto Lisi; Aurelio Maggio; Rosamaria Rosso; Giuseppe Messina; Nicola Dello Iacono; Liana Cuccia; Saveria Campisi; Massimiliano Missere; Massimo Midiri; Antonino Vallone; Stefania Renne; Nicolò Schicchi; Riccardo Righi; Maurizio Mangione; Vincenzo Positano; Alessia Pepe
Journal:  Blood Transfus       Date:  2020-07-22       Impact factor: 3.443

5.  Extramedullary haematopoiesis presenting as a periportal mass.

Authors:  Faranak Rafiee; Sara Haseli; Seyed Hamed Jafari; Pooya Iranpour
Journal:  BMJ Case Rep       Date:  2020-07-22

6.  Erythropoiesis and Iron Homeostasis in Non-Transfusion-Dependent Thalassemia Patients with Extramedullary Hematopoiesis.

Authors:  Yumei Huang; Rongrong Liu; Xiaoyun Wei; Jiaodi Liu; Lingyuan Pan; Gaohui Yang; Yongrong Lai
Journal:  Biomed Res Int       Date:  2019-01-30       Impact factor: 3.411

7.  Link between Genotype and Multi-Organ Iron and Complications in Children with Transfusion-Dependent Thalassemia.

Authors:  Antonella Meloni; Laura Pistoia; Paolo Ricchi; Maria Caterina Putti; Maria Rita Gamberini; Liana Cuccia; Giuseppe Messina; Francesco Massei; Elena Facchini; Riccardo Righi; Stefania Renne; Giuseppe Peritore; Vincenzo Positano; Filippo Cademartiri
Journal:  J Pers Med       Date:  2022-03-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.